12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers

  • FibroGen FGEN shares rose 37.1% to $1.59 during Tuesday's pre-market session. The market value of their outstanding shares is at $158.1 million. The company's, Q1 earnings came out yesterday.
  • Envoy Medical COCH stock moved upwards by 23.54% to $4.25. The company's market cap stands at $83.2 million.
  • iSpecimen ISPC shares rose 21.18% to $0.33. The company's market cap stands at $3.0 million. The company's, Q1 earnings came out today.
  • NovaBay Pharmaceuticals NBY shares moved upwards by 20.87% to $0.11. The company's market cap stands at $3.9 million.
  • GT Biopharma GTBP shares rose 19.25% to $3.84. The market value of their outstanding shares is at $5.3 million.
  • Esperion Therapeutics ESPR stock increased by 18.39% to $2.51. The company's market cap stands at $475.3 million. As per the news, the Q1 earnings report came out today.

Losers

  • Helius Medical Tech HSDT shares decreased by 16.5% to $2.02 during Tuesday's pre-market session. The company's market cap stands at $1.7 million.
  • Cellectis CLLS shares declined by 11.05% to $2.98. The company's market cap stands at $214.4 million.
  • Eledon Pharma ELDN shares fell 9.43% to $2.21. The market value of their outstanding shares is at $54.8 million.
  • Fresenius Medical Care FMS stock fell 8.03% to $19.7. The company's market cap stands at $11.5 billion.
  • Madrigal Pharmaceuticals MDGL shares declined by 7.42% to $218.1. The market value of their outstanding shares is at $4.6 billion. The company's, Q1 earnings came out today.
  • Context Therapeutics CNTX shares declined by 7.31% to $1.65. The company's market cap stands at $26.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!